FDA Inspection 1274501 — Bayer Weimar GmbH und Co. KG
The FDA completed an inspection of Bayer Weimar GmbH und Co. KG on November 24, 2022 in Weimar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 24, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Weimar (Germany)
Additional Details
Mutual Recognition Agreement (MRA)